COMP <GO>
INSP vs UFPT // FORWARD P/E MULTIPLE
Inspire Medical Systems Inc. (NYSE) VS. UFP Technologies Inc. (NASDAQ) • 15-METRIC TALLY: INSP 6
— UFPT 6
▲ FORWARD P/E MULTIPLE LEADER: INSP
LAST: $71.18 (+0.30%) • MKT CAP: $2.06B
forward-pe
11.9x
LAST: $293.30 (+2.55%) • MKT CAP: $2.27B
forward-pe
28.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSP VS. UFPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSP | UFPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.40% | 28.30% | +57.10 | INSP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | 13.90% | -7.90 | UFPT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.3x | 25.7x | -2.40 | INSP | /valuation <GO> |
| Free Cash Flow Yield | 3.81% | 4.05% | -0.24 | UFPT | /fcf-yield <GO> |
| Operating Margin | 5.60% | 15.30% | -9.70 | UFPT | /operating-margins <GO> |
| Net Profit Margin | 15.90% | 11.30% | +4.60 | INSP | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 19.50% | -5.90 | UFPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.40 | 8.31 | +3.09 | INSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.4 | 44.0 | +1.31 | INSP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 11.9x | 28.0x | -16.10 | INSP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.06B | $2.27B | -$214.0M | UFPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSP REV | UFPT REV | INSP GROSS % | UFPT GROSS % | INSP FCF | UFPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $912.0M | $602.8M | 85.4% | 28.3% | $78.5M | $91.9M |
| FY 2024 | $802.8M | $504.4M | 84.7% | 29.1% | $91.1M | $56.9M |
| FY 2023 | $624.8M | $400.1M | — | — | $24.7M | $41.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSP // BETA —
UFPT // BETA —